Keiko Hayakawa
Japanese Foundation for Cancer Research
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Keiko Hayakawa.
Japanese Journal of Clinical Oncology | 2017
Munehisa Kito; Seiichi Matusmoto; Keisuke Ae; Taisuke Tanizawa; Tabu Gokita; Hiroshi Kobayashi; Keiko Hayakawa; Yuki Funauchi
Objective We analyzed the risk factors for pulmonary metastasis from giant cell tumor of bone and aimed to discuss their therapeutic strategy and appropriate follow-up period. Methods We analyzed 141 patients of giant cell tumor of bone. The variables analyzed included age, gender, primary site, Campanacci grading, surgical treatment on the primary lesion, radiotherapy and local recurrence. Results Pulmonary metastasis occurred in 12 patients. The risk factors were young age, Campanacci Grade III and local recurrence. Median time from initial surgery to metastasis was 1.3 years (0-3.1 years). Among them, eight patients experienced local recurrence of the primary tumor, and the median time from initial surgery to local recurrence was 0.8 years (0.3-2.9 years). Among seven patients who underwent wide resection, three patients showed local recurrence of the soft tissue. Nine patients underwent metastasectomy for pulmonary metastases. Of three patients who did not undergo metastasectomy, one patient died of uncontrollable metastases, and two patients showed no changes in their metastatic lesions. Conclusions Although we found a correlation between local recurrence and pulmonary metastasis, we were still unable to prevent local or metastatic recurrence by wide resection. Local recurrence and metastasis have been found within ~3 years after initial surgery, and routine image examinations of the primary site and chest after initial surgical treatment should be considered for at least 3 years postoperatively.
Journal of Shoulder and Elbow Surgery | 2015
Taketsugu Fujibuchi; Seiichi Matsumoto; Takashi Shimoji; Keisuke Ae; Taisuke Tanizawa; Tabu Gokita; Keiko Hayakawa
BACKGROUND Endoprosthetic reconstruction of the proximal humerus is one of the standard procedures after resection of tumors of the proximal humerus and has been considered a reliable method to reconstruct the proximal humerus in recent reports. However, instability of the shoulder joint caused by loss of the rotator cuff and deltoid muscle function is often observed after such an endoprosthetic reconstruction. METHODS We performed the endoprosthesis suspension method with polypropylene monofilament knitted mesh. This suspension method, by which the endoprosthesis is suspended from the bone structure, was used after resection of tumors in 9 patients. We assessed postoperative stability of the shoulder joint by comparing these patients with 12 patients who underwent the conventional surgical technique, by which the mesh-wrapped endoprosthesis is attached only to soft tissue. RESULTS In radiographic and physical evaluation, 4 of the 12 patients in the soft tissue reconstruction group showed shoulder joint instability. No patient in the suspension method group showed subluxation of the humeral prosthesis. The mean shoulder flexion was 35° and 65° and the mean shoulder abduction was 40° and 40° for the soft tissue reconstruction group and the suspension method group, respectively. DISCUSSION Shoulder joint subluxation sometimes occurs because of elongation of the attached soft tissue in the conventional reconstruction with mesh, whereas no shoulder joint subluxation occurs after endoprosthetic reconstruction in the suspension method because the bone structure has no leeway for elongation. Excellent stability of our new method enables exercise of the surgical shoulder at an early stage, leading to improved range of shoulder joint motion.
Journal of Orthopaedic Science | 2015
Taketsugu Fujibuchi; Seiichi Matsumoto; Takashi Shimoji; Keisuke Ae; Taisuke Tanizawa; Tabu Gokita; Keiko Hayakawa; Noriko Motoi; Hiroyuki Mukai
Giant cell tumor (GCT) is classified as a benign bone tumor, but it is locally aggressive, and sometimes metastasizes in a benign state. In addition, malignant transformation occurs once in a while. Most of the secondary malignancies in GCT occur after treatment of benign GCT that has included radiation therapy [1, 2]. As a cytogenetic characteristic of GCT, telomeric associations (tas) were reported [3, 4]. Tas may generate dicentric chromosomes (dic) and chromatoid breakagefusion-bridges, which lead to chromosomal instability and tumorigenesis [5, 6]. Recently, the relationship between cytogenetic abnormalities and clinical behavior in GCT has begun to be elucidated. For example, the DNA ploidy pattern may predict the recurrence potential of GCT, chromosomal abnormalities superimposed on tas are responsible for an aggressive clinical course [7], and centrosome amplification may be useful in predicting the clinical behavior of GCT [8]. Here we report a case of secondary malignancy in GCT. Malignant transformation occurred in a relatively early period, and any radiation therapy was not administered to the primary lesion. Malignant transformation was demonstrated not only by histopathological study but also by cytogenetic analysis. The recurrent tumor, which was a secondary malignancy in GCT, had a near-triploid karyotype with multiple structural abnormalities as observed in pleomorphic sarcoma, while the primary benign GCT had a near-diploid karyotype with tas and dic.
Case reports in orthopedics | 2018
Yusuke Minami; Seiichi Matsumoto; Keisuke Ae; Taisuke Tanizawa; Keiko Hayakawa; Yuki Funauchi; Sakae Okumura; Yutaka Takazawa
Pelvic Ewing sarcoma is associated with a worse prognosis. Thromboembolic events are relatively common in pediatric patients with cancers including sarcomas. We have presented a case of Ewing sarcoma arising from the left iliac bone with tumor thrombus of inferior vena cava (IVC) which was obtained complete response by both chemotherapy and irradiation. Magnetic resonance imaging (MRI) scan demonstrated that the tumor arising from the left iliac bone extended into the left side of sacral bone, suggesting the difficulty of surgical resection. Computed tomography (CT) revealed the existence of the tumor thrombus of IVC. We performed irradiation (31.2 Gy) and chemotherapy (combination of VCR, Act-D, IFM, and ADR). The tumor was controlled successfully, and the tumor thrombus of IVC has completely vanished. Four years after the treatment, coin lesion in the left upper lung appeared. Suspected of metastasis, segmental resection of the left upper lung was performed. Fourteen years after the surgery, the patient has been remained free of recurrence. It is clinically significant for surgeons to treat pelvic Ewing sarcoma with tumor thrombus.
BMC Cancer | 2012
Jiro Ichikawa; Seiichi Matsumoto; Takashi Shimoji; Taisuke Tanizawa; Tabu Gokita; Keiko Hayakawa; Kaoru Aoki; Saori Ina; Hiroaki Kanda
BackgroundSoft tissue metastases, in particular intraneural metastasis, from any carcinomas seldom occur. To our knowledge, no case of sciatic nerve palsy due to intraneural metastasis of gastric carcinoma is reported in the literature.Case presentationA case is reported of a 82-year old woman with sciatic nerve palsy with intraneural metastasis of gastric carcinoma. Although she had undergone partial gastrectomy with T2b, N0, M0 two years ago and primary site was cured, she developed sciatic nerve palsy from the carcinoma metastasis directly to the nerve. Operative resection and Histological examination revealed poorly differentiated adenocarcinoma, the same as her primary site adenocarcinoma.ConclusionsSciatica is usually caused by a herniated disc or spinal canal stenosis. Sciatic nerve palsy may be caused by nondiscogenic etiologies that may be either intrapelvic or extrapelvic. It is important to image the entire course of the nerve to distinguish these etiologies quickly. The longer the nerve compression the less likely a palsy will recover. Surgery is a good intervention that simultaneously obtains a tissue diagnosis and decompresses the nerve.
Journal of Orthopaedics and Traumatology | 2016
Keiko Hayakawa; Seiichi Matsumoto; Keisuke Ae; Taisuke Tanizawa; Tabu Gokita; Yuki Funauchi; Noriko Motoi
Journal of Orthopaedic Science | 2018
Munehisa Kito; Seiichi Matsumoto; Keisuke Ae; Taisuke Tanizawa; Tabu Gokita; Keiko Hayakawa; Yuki Funauchi; Naoki Yamamoto
Journal of Orthopaedic Science | 2017
Munehisa Kito; Seiichi Matsumoto; Keisuke Ae; Taisuke Tanizawa; Tabu Gokita; Keiko Hayakawa; Yuki Funauchi; Yutaka Takazawa
Journal of Orthopaedic Science | 2017
Taketsugu Fujibuchi; Seiichi Matsumoto; Takashi Shimoji; Keisuke Ae; Taisuke Tanizawa; Tabu Gokita; Keiko Hayakawa; Noriko Motoi
Journal of Clinical Oncology | 2016
Kenji Nakano; Yoshiya Sugiura; Shinichiro Taira; Junichi Tomomatsu; Keiko Hayakawa; Yuki Funauchi; Tabu Gokita; Taisuke Tanizawa; Keisuke Ae; Seiichi Matsumoto; Shunji Takahashi